ReadYourDNA

Chiglitazar

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Chiglitazar

What it is

Chiglitazar is a PPAR pan-agonist that activates PPAR-alpha, -gamma and -delta, improving insulin sensitivity and blood fats. It was approved in China in 2021 for type 2 diabetes and is not approved in Europe or the US. It is sold as Bilessglu.

How genes come into it

The gene study listed, from China, looked at PPARA, the gene for one of its targets, for how much blood sugar and blood fats improved. The evidence is weak, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Chiglitazar. Upload your DNA file to see which of these rows apply to you.

Response (1 finding)

Studies of how well it worked in people carrying a variant.

PPARA rs1800234: Genotypes CC + CT is associated with decreased clinical benefit to chiglitazar in people with Diabetes Mellitus, Type 2 as compared to genotype TT.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Actos (Thiazolidinediones)

Avandia (Thiazolidinediones)

Thiazolidinediones (class) (Thiazolidinediones)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com